Freudenberg Medical Appoints New CEO
BEVERLY, MASS. – April 11, 2022 – Freudenberg Medical has announced the appointment of Dr. Mark Ostwald as CEO, effective April 1, 2022. Dr. Ostwald previously served as Chief Technology Officer of Freudenberg Medical and is part of the Management Board. He joined Freudenberg Medical in 2009 and has held a number of leadership roles including President of Europe and head of Minimally Invasive Solutions, Vice President and General Manager of the Silicones Business Unit in California, and he helped establish the Kaiserslautern, Germany operation as Managing Director of Freudenberg Medical Europe.
“I am very excited for the opportunity to lead this successful company. We will continue to partner with our customers to provide high quality, safe, and effective medical devices and components that help to improve patient outcomes,” said Dr. Ostwald. “Looking to the future, we will build on the Freudenberg strengths in process and product technology innovation as well as sustainable and lean manufacturing for the medical device and pharmaceutical industries.”
Dr. Ostwald is replacing Dr. Max Kley who has left the company to lead a new Freudenberg business group called Freudenberg Battery & Fuel Cell.
About Freudenberg Medical
Freudenberg Medical is a global partner for the design, development and manufacture of innovative medical devices, components, and product solutions. With 11 manufacturing operations and more than 2,100 associates worldwide, Freudenberg Medical offers a wide range of capabilities from precision molded components and tubing to finished devices, drug coatings, composite catheter shafts and hypotubes for minimally invasive, handheld, and catheter-based devices. www.FreudenbergMedical.de